<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html>
<head>
<title>Delafloxacin Meglumine (8:12.18 - 518004)</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="robots" content="noindex, noarchive" />
<meta name="Author" content="American Society of Health-System Pharmacists (ASHP)" />
<meta name="Copyright" content="(c) 2020, ASHP" />
<meta name="Extraction Date" content="20200929" />
<meta name="Keywords" content="" />
<!-- **********************************************************************
     
     All material distributed as part of ASHP Injectable Drug Information is copyrighted.
     Reproduction, storage on a retrieval system, or transmission of this material
     or any part thereof in any form or by any means without the express written
     permission of the American Society of Health-System Pharmacists is
     prohibited.
     
     Please contact ASHP Office of Publications at +1 (301) 657-3000
     for more detailed information.
     
     (c) Copyright, 2020, American Society of Health-System 
     Pharmacists, Inc. All Rights Reserved.
     
     ********************************************************************** --></head>
<body>
<h1 align="center">Delafloxacin Meglumine</h1>
<p align="center"><b>AHFS Class: 8:12.18 - Quinolones</b></p>
<p><b>Tradenames:</b></p>
<ul style="list-style-type:none"><li><b>Baxdela</b></li></ul>
<a name="products"></a>
<p><font face="Verdana,Arial,sans-serif" size="+1"><b><u>Products</u></b></font></p>
<p>Delafloxacin meglumine is available as a lyophilized powder in single-dose vials containing 300 mg of delafloxacin.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  Each vial also contains edetate disodium 3.4 mg, meglumine 59 mg, and sulfobutylether &#946;-cyclodextrin 2400 mg.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  The contents of each 300-mg vial should be reconstituted with 10.5 mL of dextrose 5% or sodium chloride 0.9%, and the vial should be shaken vigorously until all of the powder is dissolved to yield a 25-mg/mL solution.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </p>
<p>The reconstituted solution must be further diluted with dextrose 5% or sodium chloride 0.9% to a total volume of 250 mL prior to intravenous administration.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  To prepare a 300-mg dose, 12 mL of the infusion solution should be removed from the bag prior to addition of 12 mL (300 mg) of the drug;<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  to prepare a 200-mg dose, 8 mL of the infusion solution should be removed from the bag prior to addition of 8 mL (200 mg) of the drug.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> <a target="_blank" href="a586999.htm#r3333"><font size="-1"><sup>3333</sup></font></a> </p>
<a name="sect"></a>
<h3>&#8226; Equivalency</h3>
<p>Delafloxacin meglumine 433 mg is equivalent to 300 mg of delafloxacin as the free acid.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </p>
<a name="administration"></a>
<p><font face="Verdana,Arial,sans-serif" size="+1"><b><u>Administration</u></b></font></p>
<p>Delafloxacin meglumine is administered intravenously over 60 minutes following dilution of the reconstituted solution in sodium chloride 0.9% or dextrose 5%.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  If a common infusion line is being used to administer other drugs in addition to delafloxacin meglumine, the line should be flushed with sodium chloride 0.9% or dextrose 5% prior to and following infusion of delafloxacin meglumine.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  Delafloxacin is incompatible with any solutions that contain multivalent cations (e.g., calcium, magnesium).<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </p>
<a name="stability"></a>
<p><font face="Verdana,Arial,sans-serif" size="+1"><b><u>Stability</u></b></font></p>
<p>Delafloxacin meglumine lyophilized powder is a light yellow to tan cake that may have cracking, shrinkage, and slight variations in texture and color; upon reconstitution, a clear yellow to amber-colored solution forms.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  Intact vials of delafloxacin meglumine should be stored at controlled room temperature.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  The reconstituted solution and solutions diluted for infusion may be stored at 2 to 8&#176;C or 20 to 25&#176;C for up to 24 hours and should not be frozen.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  Any unused portions should be discarded.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  Solutions should be visually inspected for particulate matter and discoloration prior to administration.<a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </p>
<a name="compatibility"></a>
<p><font face="Verdana,Arial,sans-serif" size="+1"><b><u>Compatibility</u></b></font></p>
<a name="solution-compat"></a>
<h3>&#8226; Solution Compatibility</h3>
<table border="1" width="100%">
<caption align="top"><b>Delafloxacin meglumine</b></caption>
<thead>
<tr valign="bottom"><td><b>Test Soln Name</b></td><td><b>Test Soln Mfr</b></td><td><b>Base Drug Mfr</b></td><td><b>Base Drug Conc/L or %</b></td><td><b>Remarks</b></td><td><b>Refs</b></td><td><b>Compat</b></td></tr></thead>
<tbody>
<tr valign="top"><td><a name="sc575042"></a>Dextrose 5% in Ringer&#8217;s injection</td><td></td><td>MEL</td><td></td><td>Must not be mixed with calcium-containing solutions</td><td><a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </td><td><font color="red"><b>I</b></font></td></tr>
<tr valign="top"><td><a name="sc575042"></a>Dextrose 5% in Ringer&#8217;s injection, lactated</td><td></td><td>MEL</td><td></td><td>Must not be mixed with calcium-containing solutions</td><td><a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </td><td><font color="red"><b>I</b></font></td></tr>
<tr valign="top"><td><a name="sc575042"></a>Dextrose 5%</td><td></td><td>MEL</td><td>0.8, 1.2 g</td><td>Stable for up to 24 hr at 2 to 8&#176;C or 20 to 25&#176;C</td><td><a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  <a target="_blank" href="a586999.htm#r3333"><font size="-1"><sup>3333</sup></font></a> </td><td><font color="green">C</font></td></tr>
<tr valign="top"><td><a name="sc575042"></a>Dextrose 5%</td><td>BRN<a href="#sol-f2"><font size="-1"><sup>b</sup></font></a> </td><td>MEL</td><td>0.2, 3.2, and 3.75 g</td><td>Compatible and stable for up to 48 hr protected from light at 2 to 8&#176;C or 25&#176;C with 60% relative humidity</td><td><a target="_blank" href="a586999.htm#r3333"><font size="-1"><sup>3333</sup></font></a> </td><td><font color="green">C</font></td></tr>
<tr valign="top"><td><a name="sc575042"></a>Dextrose 5%</td><td>BA<a href="#sol-f2"><font size="-1"><sup>b</sup></font></a> </td><td>MEL</td><td>1.1 g</td><td>Compatible for up to 48 hr protected from light at 5&#176;C or 25&#176;C with 60% relative humidity</td><td><a target="_blank" href="a586999.htm#r3333"><font size="-1"><sup>3333</sup></font></a> </td><td><font color="green">C</font></td></tr>
<tr valign="top"><td><a name="sc575042"></a>Dextrose 5%</td><td>HOS<a href="#sol-f1"><font size="-1"><sup>a</sup></font></a> </td><td>MEL</td><td>1.1 g</td><td>Compatible for up to 48 hr protected from light at 5&#176;C or 25&#176;C with 60% relative humidity</td><td><a target="_blank" href="a586999.htm#r3333"><font size="-1"><sup>3333</sup></font></a> </td><td><font color="green">C</font></td></tr>
<tr valign="top"><td><a name="sc575042"></a>Dextrose 5%</td><td>BA<a href="#sol-f3"><font size="-1"><sup>c</sup></font></a> </td><td>MEL</td><td>1.1 g</td><td>Compatible for up to 48 hr protected from light at 5&#176;C or 25&#176;C with 60% relative humidity</td><td><a target="_blank" href="a586999.htm#r3333"><font size="-1"><sup>3333</sup></font></a> </td><td><font color="green">C</font></td></tr>
<tr valign="top"><td><a name="sc565216"></a>Ringer&#8217;s injection</td><td></td><td>MEL</td><td></td><td>Must not be mixed with calcium-containing solutions</td><td><a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </td><td><font color="red"><b>I</b></font></td></tr>
<tr valign="top"><td><a name="sc565217"></a>Ringer&#8217;s injection, lactated</td><td></td><td>MEL</td><td></td><td>Must not be mixed with calcium-containing solutions</td><td><a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a> </td><td><font color="red"><b>I</b></font></td></tr>
<tr valign="top"><td><a name="sc582185"></a>Sodium chloride 0.9%</td><td></td><td>MEL</td><td>0.8, 1.2 g</td><td>Stable for up to 24 hr at 2 to 8&#176;C or 20 to 25&#176;C</td><td><a target="_blank" href="a586999.htm#r3332"><font size="-1"><sup>3332</sup></font></a>  <a target="_blank" href="a586999.htm#r3333"><font size="-1"><sup>3333</sup></font></a> </td><td><font color="green">C</font></td></tr>
<tr><td colspan="8">
<a name="sol-f1"></a>
<font color="green" size="-1"><sup>a</sup></font> <font size="-1" face="verdana">Tested in PVC containers.</font>
<a name="sol-f2"></a>
<br /><font color="green" face="verdana" size="-1"><sup>b</sup></font> <font size="-1" face="verdana">Tested in polyolefin containers.</font>
<a name="sol-f3"></a>
<br /><font color="green" face="verdana" size="-1"><sup>c</sup></font> <font size="-1" face="verdana">Tested in polyethylene containers.</font>
</tbody></table>
<table border="0" width="100%">
<tr><td>ASHP<sup>&#174;</sup> Injectable Drug Information<sup>&trade;</sup>. &#169; Copyright, 1977-2020. American Society of Health-System Pharmacists<sup>&#174;</sup>, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.<br />Original Publication Date: February 21, 2018. <br />Database Extraction: 09/29/2020 18:17:58 -0400+</td>
<td><a href="http://www.ahfsdruginformation.com"><img src="images/ashp1RGB.jpg" alt="ASHP" border="0" height="50" width="100"/></a></td></tr>
</table>
<a name="refs"></a>
<p><font face="Verdana,Arial,sans-serif" size="+1"><b><u>References</u></b></font></p>
<p><a target="_blank" href="a586999.htm">For a list of references cited in the text of this monograph, search the monograph titled <i>References</i>.</a></p>
</body>
</html>
